Stay updated on SAGE-547 for Status Epilepticus Clinical Trial
Sign up to get notified when there's something new on the SAGE-547 for Status Epilepticus Clinical Trial page.

Latest updates to the SAGE-547 for Status Epilepticus Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe new screenshot indicates styling/layout changes to the page without altering core study information (eligibility, interventions, or outcomes). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoNo Change Detected
- Check43 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference7%

- Check50 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0 to reflect a newer version.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page now references Supernus Pharmaceuticals, Inc. with newer dates (2025) and a revised update label, replacing Sage Therapeutics and older 2017 dates. This indicates a branding/ownership update and refreshed timestamping.SummaryDifference3%

- Check64 days agoChange DetectedThe page now shows Revision: v3.0.2 (replacing v3.0.1), and the Back to Top link was removed.SummaryDifference0.4%

- Check71 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.4%

Stay in the know with updates to SAGE-547 for Status Epilepticus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-547 for Status Epilepticus Clinical Trial page.